MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0007008
Biotech Consortium India Limited - business outsourcing in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.12 Cr
▲ 7% YoY
Net profit · FY 2025
₹5.1 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹11.5 Lakh
EBITDA margin 1.9%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.37 Cr
Issued & subscribed
Company age
36 yrs
Est. 1990
Employees · EPFO
28
Provident fund records
Directors on board
11
As per MCA filings
About Biotech Consortium India Limited
Data last updated:
Biotech Consortium India Limited is a public limited company based in New Delhi, Delhi, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 14 September 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL1990PLC041486. Its GSTIN is 07AAACB1113A1ZR (Delhi).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.37 Cr. It is led by directors including Purnima Sharma (Managing Director) and Sanjeev Khosla.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th Floor Anuvrat Bhawan210 Deen Dayal Upadhyaya Marg, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.12 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.1 Lakh (net margin 0.8%) and EBITDA of ₹11.5 Lakh (EBITDA margin 1.9%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 12% over five years.
The company has about 28 employees on its provident fund (EPFO) records.
The company is associated with 4 brands: Rasa Life Science Informatics, National Biopharma Mission, BCIL and Biotech Consortium India Limited. Court records list 10 cases involving the company, including 4 filed by the company and 6 filed against it.
Biotech Consortium India Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0007008). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biotech.co.in.
Company details
CIN U73100DL1990PLC041486
Registration Number 041486
Incorporation Date 14 September 1990
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0007008
Key People
Purnima Sharma Managing Director Sanjeev Khosla Nominee Director Shashank Dixit Nominee Director Recognitions & Rankings of Biotech Consortium India
Contact details
Biotech Consortium India Limited's registered office is in New Delhi, Delhi. Its website is biotech.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address5th Floor Anuvrat Bhawan210 Deen Dayal Upadhyaya Marg, New Delhi, Delhi, India – 110002
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Biotech Consortium India Limited, buy the company report.
Comprehensive company report
Biotech Consortium India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biotech Consortium India operates multiple associated brands including Rasa Life Science Informatics, National Biopharma Mission, and BCIL. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides bioinformatics courses, workshops, research training, and consultancy services. | rasalsi.com | |
| Laboratory training is provided to biotechnology students through exams. | bcil.nic.in | |
| Biopharmaceutical skill development and training programs in India. | nbmworkshops.com | |
| Biotech Consortium India Limited is engaged in biotechnology commercialization services. | biotech.co.in |
Business activity
The main business activity of Biotech Consortium India is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Biotech Consortium India Limited, buy the company report.
Financials of Biotech Consortium India Limited
FY 2025 filings availableBiotech Consortium India Limited reported revenue of ₹6.12 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹6.12 Cr ▲ 7%
Net profit · FY 2025
₹5.1 Lakh margin 0.8%
EBITDA · FY 2025
₹11.5 Lakh margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 2%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▼ 17%
5 years · compounded
▼ 42%
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biotech Consortium India Limited, buy the company report.
Board of directors of Biotech Consortium India Limited
Biotech Consortium India has 11 current directors and 31 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Khosla | Nominee Director | 28 Oct 2020 | 6 Years 0 Months | Current |
| Shashank Dixit | Nominee Director | 08 May 2025 | 1 Years 5 Months | Current |
| Phadnis Ramarao Suresh | Nominee Director | 06 Sep 2011 | 15 Years 1 Months | Current |
| Purnima Sharma | Managing Director | 21 Nov 2005 | 20 Years 11 Months | Current |
| Ram Vishwakarma Asrey | Additional Director | 28 Oct 2020 | 6 Years 0 Months | Current |
| Tilak Raj Sharma | Nominee Director | 30 Mar 2021 | 5 Years 6 Months | Current |
Showing 6 of 11 current directors. View all directors
Peer comparison
Biotech Consortium India Limited is compared with the 3 companies closest to it by revenue in the Business Services industry (Business Auxiliary Services, Consulting Services), with the same principal business activity (management consultancy activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prowis Corporate Services Private Limited | ₹6.12 Cr (FY 2025) | 45.0% | Chennai, Tamil Nadu, India | |||
| Biotech Consortium India Limitedthis company | ₹6.12 Cr (FY 2025) | ₹5.1 Lakh | 0.8% | 7.0% | 28 | New Delhi, Delhi, India |
| DG Growth Ventures Private Limited | ₹6.12 Cr (FY 2025) | 24.0% | Ludhiana, Punjab, India | |||
| United Eco Care Consultancy Private Limited | ₹6.1 Cr (FY 2025) | 47.0% | Cuttack, Odisha, India |
To see the full peer comparison of Biotech Consortium India Limited, buy the company report.
Auditor
Biotech Consortium India Limited is audited by Surendra Subhash and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Surendra Subhash and Company | FY 2023 | 003173N |
Shareholding
The shareholding of Biotech Consortium India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biotech Consortium India Limited, buy the company report.
Legal cases
Biotech Consortium India Limited has 10 court cases on record: 4 filed by Biotech Consortium India, 6 filed against it. All cases are disposed.
Total cases
10
Filed by the company
4
Filed against the company
6
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 3 | 0 |
| High courts | 3 | 3 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Court case (T.P. C) | Filed against the company by an individual | Disposed |
| District court, South East, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
| District court, South East, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
| District court, South East, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
To see the full case history of Biotech Consortium India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Biotech Consortium India Limited has 28 MSME Form 1 returns on record between 2018 and 2023, listing 85 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rna, Ip Attorneys | |||
| Aumirah SKB Private Limited | |||
| Surendra Subhash and Company | |||
| Skyline Financial Services Private Limited |
To see the full MSME payment records of Biotech Consortium India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Biotech Consortium India Limited has a workforce of 28 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
28
Active EPFO establishments
1
Employee growth
-3.45%
GST
Biotech Consortium India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACB1113A1ZR | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biotech Consortium India Limited, buy the company report.
Recent activity
Biotech Consortium India Limited has 42 board changes on record since 2005: 11 appointments and 31 cessations. The latest: Shashank Dixit was appointed as Nominee Director on 08 May 2025.
AGM
Biotech Consortium India Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Appointed
Shashank Dixit was appointed as Nominee Director.
Appointed
Smita Kumar was appointed as Nominee Director.
Ceased
Ranjan Kumar Rath ceased to be Nominee Director.
Filing
Biotech Consortium India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Sanghamitra Pati was appointed as Nominee Director.
Ceased
Phadnis Ramarao Suresh ceased to be Nominee Director.
Ceased
Chander Shekhar ceased to be Nominee Director.
Ceased
Manju Sharma ceased to be Director.
Appointed
Shekhar Chintamani Mande was appointed as Additional Director.
Ceased
Ved Prakash Kamboj ceased to be Director.
Appointed
Ranjan Kumar Rath was appointed as Nominee Director.
33 earlier events are in the company report.
Frequently asked questions
Biotech Consortium India is an active public limited company based in New Delhi, Delhi, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 14 September 1990 (36+ years old) and is registered under CIN U73100DL1990PLC041486.
Biotech Consortium India has 11 current directors:
- Purnima Sharma - Managing Director
- Sanjeev Khosla - Nominee Director
- Shashank Dixit - Nominee Director
- Phadnis Ramarao Suresh - Nominee Director
- Ram Vishwakarma Asrey - Additional Director
- Tilak Raj Sharma - Nominee Director
- Ranjan Kumar Rath - Nominee Director
- Anita Gupta - Nominee Director
- Shekhar Chintamani Mande - Additional Director
- Smita Kumar - Nominee Director
- Sanghamitra Pati - Nominee Director
The latest financial statements of Biotech Consortium India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biotech Consortium India is 07AAACB1113A1ZR, registered in Delhi.
The CIN (Corporate Identification Number) of Biotech Consortium India is U73100DL1990PLC041486. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotech Consortium India has 10 court cases on record: 4 filed by the company and 6 filed against it. Most are in the district courts.
Biotech Consortium India was incorporated on 14 September 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biotech Consortium India by revenue are Prowis Corporate Services Private Limited, DG Growth Ventures Private Limited, United Eco Care Consultancy Private Limited, all in the Business Services industry (Business Auxiliary Services, Consulting Services), with the same principal business activity (management consultancy activities).
Shashank Dixit was appointed as Nominee Director on 08 May 2025. Smita Kumar was appointed as Nominee Director on 08 May 2025. Ranjan Kumar Rath ceased to be Nominee Director on 30 Apr 2025. Biotech Consortium India has 42 board changes on record in total.
Yes, Biotech Consortium India is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0007008).
Biotech Consortium India has 28 MSME Form 1 returns on record between 2018 and 2023, listing 85 overdue payments to 4 micro and small suppliers. The latest return was filed on 29 Nov 2023.
Biotech Consortium India can be reached through the website biotech.co.in. Its registered office is in New Delhi, Delhi, India.